Table 1 Cancer types and their respective sample sizes

Bladder urothelial carcinoma (TCGA, Nature 2014) [47]

1

127

Breast invasive carcinoma (TCGA, Cell 2015) [48]

2

973

Colorectal adenocarcinoma (TCGA, Nature 2012) [49]

3

212

Glioblastoma (TCGA, Cell 2013) [50]

4

280

Head and neck squamous cell carcinoma (TCGA, Nature 2015) [51]

5

279

Kidney renal clear cell carcinoma (TCGA, Nature 2013) [52]

6

418

Acute myeloid leukaemia (TCGA, NEJM 2013) [53]

7

190

Lung adenocarcinoma (TCGA, Nature 2014) [54]

8

230

Lung squamous cell carcinoma (TCGA, Nature 2012) [55]

9

178

Ovarian serous cystadenocarcinoma (TCGA, Nature 2011) [56]

10

316

Uterine corpus endometrial carcinoma (TCGA, Nature 2013) [57]

11

240

Adenoid cystic carcinoma (MSKCC, Nat Genet 2013) [58]

12

55

Brain lower grade glioma (TCGA, Provisional)

13

279

Cervical squamous cell carcinoma and endocervical adenocarcinoma (TCGA, Provisional)

14

191

Kidney renal papillary cell carcinoma (TCGA, Provisional)

15

161

Liver hepatocellular carcinoma (AMC, Hepatology 2014) [59]

16

231

Pancreatic adenocarcinoma (TCGA, Provisional)

17

145

Prostate adenocarcinoma (TCGA, Cell 2015) [60]

18

332

Skin cutaneous melanoma (TCGA, Provisional)

19

278

Stomach adenocarcinoma (TCGA, Nature 2014) [61]

20

287

Papillary thyroid carcinoma (TCGA, Cell 2014) [62]

21

399

Adrenocortical carcinoma (TCGA, Provisional)

22

88

Kidney chromophobe (TCGA, Cancer Cell 2014) [63]

23

65

Pheochromocytoma and paraganglioma (TCGA, Provisional)

24

161

Sarcoma (TCGA, Provisional)

25

240

Testicular germ cell cancer (TCGA, Provisional)

26

149

Uterine carcinosarcoma (TCGA, Provisional)

27

56

Uveal melanoma (TCGA, Provisional)

28

80